Draulio de Araujo
Neuroscientist and Clinical Researcher
Papers
Trials
Key Impact
Noted for leading neuroimaging and clinical investigations of ayahuasca and other psychedelics that have advanced understanding of their neural signatures and rapid antidepressant potential.
Background & Research
Draulio de Araujo is a Brazilian neuroscientist and clinical researcher whose work intersects neuroimaging, psychopharmacology and clinical trials of classical and plant-derived psychedelics. He has been a senior author and collaborator on a series of influential studies using fMRI, SPECT and EEG to characterise the neural correlates of the ayahuasca and DMT states, and has contributed to clinical work reporting rapid antidepressant effects of single-dose ayahuasca in patients with recurrent or treatment-resistant depression. His publications also span experimental investigations of LSD in healthy volunteers, including studies of cognition, creativity and the phenomenology of altered thought-streams.